skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Martinez-Marti, A ; Felip, E ; Matito, J ; Mereu, E ; Navarro, A ; Cedrés, S ; Pardo, N ; Martinez de Castro, A ; Remon, J ; Miquel, J M ; Guillaumet-Adkins, A ; Nadal, E ; Rodriguez-Esteban, G ; Arqués, O ; Fasani, R ; Nuciforo, P ; Heyn, H ; Villanueva, A ; Palmer, H G ; Vivancos, A

Annals of oncology, 2017-10, Vol.28 (10), p.2451-2457 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
2
DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Martinez-Marti, A. ; Felip, E. ; Matito, J. ; Mereu, E. ; Navarro, A. ; Cedrés, S. ; Pardo, N. ; Martinez de Castro, A. ; Remon, J. ; Miquel, J.M. ; Guillaumet-Adkins, A. ; Nadal, E. ; Rodriguez-Esteban, G. ; Arqués, O. ; Fasani, R. ; Nuciforo, P. ; Heyn, H. ; Villanueva, A. ; Palmer, H.G. ; Vivancos, A.

Annals of oncology, 2017-10, Vol.28 (10), p.2451-2457 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m
KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m
Material Type:
Artigo 		Adicionar ao Meu Espaço

KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m

Aranda, N. Pardo ; Ruiz, F. ; Marti, A. Martinez ; Cedres, S. ; Mendivil, A. Navarro ; fuente, Idela ; de Castro, A. Martinez ; Vivancos, A. ; Dienstmann, R. ; Felip, E.

Annals of oncology, 2016-10, Vol.27, p.vi440-vi440 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome

Cedres Perez, S. ; Sanso, M. ; Hernando-Calvo, A. ; Callejo, A. ; Pardo Aranda, N. ; Navarro Mendivil, A. ; Martinez, A. ; Remon, J. ; Miquel, J.M. ; Rodriguez, G. ; Monton, V. ; Villacampa, G. ; Dienstmann, R. ; Vivancos, A. ; Felip Font, E.

Annals of oncology, 2018-10, Vol.29, p.viii641-viii641 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials

Cedres, S. ; Aranda, N. Pardo ; de Castro, A. Martinez ; Mendivil, A. Navarro ; Marti, A. Martinez ; Ortiz, C. ; Racca, F. ; Vilaro, M. ; Carbonell, L. ; Piera, A. ; fuente, Idela ; Felip, E.

Annals of oncology, 2016-10, Vol.27, p.vi440-vi440 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation

Viteri, S. ; Chang, G.-C. ; Chiari, R. ; Cho, B.C. ; Ciardiello, F. ; Curigliano, G. ; Hida, T. ; Lee, D.H. ; Lim, W.T.D. ; Lin, C.-C. ; Martinez, A. ; Murakami, H. ; Natsume, I. ; Nishio, M. ; Paz-Ares, L. ; Soo, R.A. ; Cattan, V. ; Gandossi, E. ; Heck, H. ; Park, K.

Annals of oncology, 2018-10, Vol.29, p.viii525-viii525 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

Tarazona, N. ; Gimeno-Valiente, F. ; Gambardella, V. ; Zuñiga, S. ; Rentero-Garrido, P. ; Huerta, M. ; Roselló, S. ; Martinez-Ciarpaglini, C. ; Carbonell-Asins, J.A. ; Carrasco, F. ; Ferrer-Martínez, A. ; Bruixola, G. ; Fleitas, T. ; Martín, J. ; Tébar-Martínez, R. ; Moro, D. ; Castillo, J. ; Espí, A. ; Roda, D. ; Cervantes, A.

Annals of oncology, 2019-11, Vol.30 (11), p.1804-1812 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Comparison of four prognostic scores in peripheral T-cell lymphoma
Comparison of four prognostic scores in peripheral T-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of four prognostic scores in peripheral T-cell lymphoma

Gutiérrez-García, G. ; García-Herrera, A. ; Cardesa, T. ; Martínez, A. ; Villamor, N. ; Ghita, G. ; Martínez-Trillos, A. ; Colomo, L. ; Setoain, X. ; Rodríguez, S. ; Giné, E. ; Campo, E. ; López-Guillermo, A.

Annals of oncology, 2011-02, Vol.22 (2), p.397-404 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Mazieres, J. ; Drilon, A. ; Lusque, A. ; Mhanna, L. ; Cortot, A.B. ; Mezquita, L. ; Thai, A.A. ; Mascaux, C. ; Couraud, S. ; Veillon, R. ; Van den Heuvel, M. ; Neal, J. ; Peled, N. ; Früh, M. ; Ng, T.L. ; Gounant, V. ; Popat, S. ; Diebold, J. ; Sabari, J. ; Zhu, V.W. ; Rothschild, S.I. ; Bironzo, P. ; Martinez-Marti, A. ; Curioni-Fontecedro, A. ; Rosell, R. ; Lattuca-Truc, M. ; Wiesweg, M. ; Besse, B. ; Solomon, B. ; Barlesi, F. ; Schouten, R.D. ; Wakelee, H. ; Camidge, D.R. ; Zalcman, G. ; Novello, S. ; Ou, S.I. ; Milia, J. ; Gautschi, O.

Annals of oncology, 2019-08, Vol.30 (8), p.1321-1328 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma
Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma

Magnano, L. ; Balagué, O. ; Dlouhy, I. ; Rovira, J. ; Karube, K. ; Pinyol, M. ; Rivas-Delgado, A. ; Costa, D. ; Martínez-Trillos, A. ; González-Farre, B. ; Martínez-Pozo, A. ; Giné, E. ; Colomer, D. ; Delgado, J. ; Villamor, N. ; Campo, E. ; López-Guillermo, A.

Annals of oncology, 2017-11, Vol.28 (11), p.2799-2805 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.